Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease | Journal of Clinical Oncology | 2001 | 801 |
The Intergroup Rhabdomyosarcoma Study-I. A final report | Cancer | 1988 | 752 |
Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma Study | Cancer | 1995 | 452 |
The Intergroup Rhabdomyosarcoma Study-II | Cancer | 1993 | 451 |
Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification | Proceedings of the National Academy of Sciences of the United States of America | 1989 | 315 |
Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study | Leukemia | 1999 | 263 |
Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study | Journal of Clinical Oncology | 2001 | 251 |
Obstacles and opportunities for the use of health-related quality-of-life assessment in pediatric cancer clinical trials (discussion) | International Journal of Cancer | 1999 | 250 |
Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation | Journal of Clinical Oncology | 2000 | 227 |
Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update | Journal of Clinical Oncology | 2017 | 213 |
Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma | Cancer | 1982 | 166 |
A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group | International Journal of Radiation Oncology Biology Physics | 1998 | 164 |
"Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group Study | Journal of Neuropathology and Experimental Neurology | 2000 | 156 |
Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group | Medical and Pediatric Oncology | 1999 | 144 |
Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study | Journal of Clinical Oncology | 2000 | 136 |
Trends in Use of Medical Imaging in US Health Care Systems and in Ontario, Canada, 2000-2016 | JAMA - Journal of the American Medical Association | 2019 | 135 |
Late effects of therapy in orbital rhabdomyosarcoma in children. A report from the Intergroup Rhabdomyosarcoma Study | Cancer | 1986 | 135 |
Prognostic factors in infants and very young children with intracranial ependymomas | Pediatric Neurosurgery | 1998 | 133 |
Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study | International Journal of Radiation Oncology Biology Physics | 1993 | 130 |
Lymphatic metastases with childhood rhabdomyosarcoma. A report from the Intergroup Rhabdomyosarcoma Study | Cancer | 1987 | 120 |
Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups | Cancer | 1996 | 118 |
Intellectual outcome in children and adolescents with acute lymphoblastic leukaemia treated with chemotherapy alone: age- and sex-related differences | European Journal of Cancer | 2003 | 114 |
Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study | Blood | 2007 | 112 |
Neuroblastoma. Effect of genetic factors on prognosis and treatment | Cancer | 1992 | 111 |
Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study | Journal of Clinical Oncology | 1999 | 108 |